INTENSIVE LIPID-LOWERING THERAPY IS HIGHLY COST-EFFECTIVE IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION: A TWO-YEAR FOLLOW - UP OF "JENA AUF ZIEL"

被引：0
|
作者：
Haertel, Franz [1 ]
Geiling, Jens [1 ]
Makhmudova, Umidakhon [2 ]
Kraeplin, Thomas [1 ]
Otto, Sylvia [1 ]
Maerz, Winfried [3 ]
Schulze, Christian [1 ]
Weingartner, Oliver [1 ]
机构：
[1] Univ Hosp Jena, Cardiol, Jena, Germany
[2] Charite, Cardiol, Berlin, Germany
[3] Internal Med V, Endocrinology, Mannheim, Germany
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SaaG080
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Intensive lipid - lowering therapy is highly cost effective in patients with ST - elevation myocardial infarction: a two - year follow - up of Jena auf Ziel
    Haertel, F.
    Makhmudova, U.
    Geiling, J. A.
    Kraeplin, T.
    Otto, S.
    Maerz, W.
    Schulze, P. C.
    Weingaertner, O.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [2] FOLLOW-UP IN SPECIALIZED LIPID CLINICS OPTIMIZES LIPID-LOWERING THERAPIES IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION: A TWO- YEAR FOLLOW-UP OF "JENA AUF ZIEL"
    Haertel, Franz
    Geiling, Jens
    Makhmudova, Umidakhon
    Otto, Sylvia
    Schulze, Christian
    Weingartner, Oliver
    ATHEROSCLEROSIS, 2024, 395
  • [3] Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction ("Jena auf Ziel")
    Makhmudova, Umidakhon
    Samadifar, Beasat
    Maloku, Aurel
    Haxhikadrija, Pellumb
    Geiling, Jens-Arndt
    Roemer, Robert
    Lauer, Bernward
    Moebius-Winkler, Sven
    Otto, Sylvia
    Schulze, P. Christian
    Weingaertner, Oliver
    CLINICAL RESEARCH IN CARDIOLOGY, 2023, 112 (09) : 1212 - 1219
  • [4] Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (“Jena auf Ziel”)
    Umidakhon Makhmudova
    Beasat Samadifar
    Aurel Maloku
    Pellumb Haxhikadrija
    Jens-Arndt Geiling
    Robert Römer
    Bernward Lauer
    Sven Möbius-Winkler
    Sylvia Otto
    P. Christian Schulze
    Oliver Weingärtner
    Clinical Research in Cardiology, 2023, 112 : 1212 - 1219
  • [5] Jena auf Ziel: get all patients with ST-elevation myocardial infarction on EAS/ESC-LDL-C targets
    Makhmudova, U.
    Samadifar, B.
    Maloku, A.
    Haxhikadrija, P.
    Otto, S.
    Schulze, P. C.
    Weingaertner, O.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2334 - 2334
  • [6] Vasoprotective effect of effective lipid-lowering therapy in patients with ST-segment elevation infarction
    Salyamova, Ludmila I.
    Khromova, Angelina A.
    Kvasova, Olga G.
    V. Avdeeva, Irina
    Borisova, Natalia A.
    Korenkova, Karina N.
    Polezhaeva, Kristina N.
    Oleynikov, Valentin E.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (12) : 1355 - 1360
  • [7] Enoxaparin is a Cost-Effective Adjunct to Fibrinolytic Therapy for ST-Elevation Myocardial Infarction in Contemporary Practice
    Menown, Ian
    Montalescot, Gilles
    Pal, Nikhal
    Fidler, Carrie
    Orme, Michelle
    Gillard, Samantha
    ADVANCES IN THERAPY, 2010, 27 (03) : 181 - 191
  • [8] Enoxaparin is a cost-effective adjunct to fibrinolytic therapy for ST-elevation myocardial infarction in contemporary practice
    Ian Menown
    Gilles Montalescot
    Nikhal Pal
    Carrie Fidler
    Michelle Orme
    Samantha Gillard
    Advances in Therapy, 2010, 27 : 181 - 191
  • [9] Inhaled Nitric Oxide in ST-Elevation Myocardial Infarction: Two Year Follow-up of the NOMI Study
    Vanhaverbeke, Maarten
    Bogaert, Jan
    Merkely, Bela
    Zalewski, Jaroslaw
    Vranckx, Pascal
    Pokreisz, Peter
    Sinnaeve, Peter
    Belmans, Ann
    Janssens, Stefan
    CIRCULATION, 2016, 134
  • [10] JENA AUF ZIEL - JAZ" - A PROSPECTIVE COHORT STUDY AIMING TO GET ALL PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION ON ESC/EAS LDL-C TARGETS
    Makhmudova, U.
    Samadifar, B.
    Maloku, A.
    Haxhikadrija, P.
    Otto, S.
    Schulze, P. C.
    Weingaertner, O.
    ATHEROSCLEROSIS, 2022, 355 : E320 - E321
12345